STOCKS END MIXED EVEN AS POWELL SOOTHES RATE NERVES

Fed chair: "It is unlikely the next policy move will be a hike"

Eliem Therapeutics, Inc. (ELYM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Add to watchlist

7.57

+0.48

(+6.77%)

At close: 04:00PM EDT

7.30

-0.27

(-3.57%)

After hours:

05:02PM EDT

Trade prices are not sourced from all markets

All

GlobeNewswire
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
Transaction to add clinical-stage program directed towards treating unmet needs in autoantibody-mediated diseases Combined company expected to have approximately $210 million of cash and cash equivalents, including $120 million from a concurrent private placement of common stock from leading life sciences investors Combined company to focus on clinical development of lead product candidate, TNT119, in upcoming Phase 2 clinical trials in systemic lupus erythematosus and immune thrombocytopenia Co
Simply Wall St.
Here's Why We're Not Too Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Situation
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Simply Wall St.
Eliem Therapeutics (NASDAQ:ELYM) Is In A Good Position To Deliver On Growth Plans
Just because a business does not make any money, does not mean that the stock will go down. For example, although...